A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension
Clinical trial NCT04936035 · COMPLETED
Trial details
- NCT number
- NCT04936035
- Sponsor
- Alnylam Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-07
- Primary completion
- 2023-04-04
- Enrollment
- 394
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.